Association of early radiographic damage with impaired physical function in rheumatoid arthritis: A ten-year, longitudinal observational study in 238 patients

Arthritis and Rheumatism

Volumn 54, Issue 1, 2006, Pages 68-75

  Ødegård, Sigrid ^a   Landewé, Robert ^b   Van Der Heijde, Désirée ^b   Kvien, Tore K ^a   Mowinckel, Petter ^a   Uhlig, Till ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; GRIP STRENGTH; HAND RADIOGRAPHY; HEALTH ASSESMENT QUESTIONNAIRE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHYSICAL DISABILITY; PHYSICAL DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY;

EID: 31044433510     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21548     Document Type: Article

References (48)

1. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
2. Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924-7.
3. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
4. Wick MC, Lindblad S, Klareskog L, van Vollenhoven RF. Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description. Ann Rheum Dis 2004;63:848-52.
5. Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 2003;21 Suppl 31:520-7.
6. Guillemin F, Briancon S, Pourel J. Functional disability in rheumatoid arthritis: two different models in early and established disease. J Rheumatol 1992;19:366-9.
7. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000;39:122-32.
8. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
9. Park T, Lee SY. A test of missing completely at random for longitudinal data with missing observations. Stat Med 1997;16: 1859-71.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Smedstad LM, Moum T, Guillemin F, Kvien TK, Finch MB, Suurmeijer TP, et al. Correlates of functional disability in early rheumatoid arthritis: a cross-sectional study of 706 patients in four European countries. Br J Rheumatol 1996;35:746-51.
12. Smedstad LM, Vaglum P, Moum T, Kvien TK. The relationship between psychological distress and traditional clinical variables: a 2 year prospective study of 216 patients with early rheumatoid arthritis. Br J Rheumatol 1997;36:1304-11.
13. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
14. Massy-Westropp N, Rankin W, Ahern M, Krishnan J, Hearn TC. Measuring grip strength in normal adults: reference ranges and a comparison of electronic and hydraulic instruments. J Hand Surg [Am] 2004;29:514-9.
15. Escalante A, Haas RW, del Rincon I. Measurement of global functional performance in patients with rheumatoid arthritis using rheumatology function tests. Arthritis Res Ther 2004;6:R315-25.
16. Swinkels HL, Laan RF, van't Hof MA, van der Heijde DM, de Vries N, van Riel PL. Modified Sharp method: factors influencing reproducibility and variability. Semin Arthritis Rheum 2001;31: 176-90.
17. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
18. Van der Heijde D, Boonen A, Boers M, Kostense P, van der Linden S. Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology (Oxford) 1999;38:1213-20.
19. Van Leeuwen MA, Westra J, van Riel PL, Limburg PC, van Rijswijk MH. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
20. Van der Heijde D, Simon L, Smolen J, Strand V, Sharp J, Boers M, et al. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum 2002;47:215-8.
21. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
22. Kobelt G, Eberhardt K, Jonsson L, Jonsson B. Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum 1999;42:347-56.
23. Korthals-de Bos I, van Tulder M, Boers M, Verhoeven AC, Ader HJ, Bibo J, et al. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol 2004;31:1709-16.
24. Van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21: 425-9.
25. Plant MJ. Radiological progression and outcome in early rheumatoid arthritis. London: University of London; 1996.
26. Eberhardt KB, Fex E. Functional impairment and disability in early rheumatoid arthritis: development over 5 years. J Rheumatol 1995;22:1037-42.
27. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999; 42:1854-60.
28. Kaarela K, Sarna S. Correlations between clinical facets of outcome in rheumatoid arthritis. Clin Exp Rheumatol 1993;11:643-4.
29. Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123-9.
30. Bruhlmann P, Stucki G, Michel BA. Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. J Rheumatol 1994;21:1245-9.
31. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 1989;110:259-66.
32. Hakala M, Nieminen P, Koivisto O. More evidence from a community based series of better outcome in rheumatoid arthritis: data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 1994;21:1432-7.
33. Uhlig T, Smedstad LM, Vaglum P, Moum T, Gerard N, Kvien TK. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology (Oxford) 2000;39:732-41.
34. Welsing PM, Landewe RB, van Riel PL, Boers M, van Gestel AM, van der Linden S, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004;50:2082-93.
35. Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford) 1999; 38:228-34.
36. Vliet Vlieland TP, Buitenhuis NA, van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM. Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 1994;53:803-6.
37. Ward MM, Leigh JP. The relative importance of pain and functional disability to patients with rheumatoid arthritis. J Rheumatol 1993;20:1494-9.
38. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
39. Wolfe F, Hawley DJ. The relationship between clinical activity and depression in rheumatoid arthritis. J Rheumatol 1993;20:2032-7.
40. Abdel-Nasser AM, El-Azim S, Taal E, El-Badawy SA, Rasker JJ, Valkenburg HA. Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol 1998;37:391-7.
41. Arvidson NG, Larsson A, Larsen A. Simple function tests, but not the modified HAQ, correlate with radiological joint damage in rheumatoid arthritis. Scand J Rheumatol 2002;31:146-50.
42. Twisk JW. Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study. Int J Sports Med 1997;18 Suppl 3:S216-24.
43. Twisk J, de Vente W. Attrition in longitudinal studies: how to deal with missing data. J Clin Epidemiol 2002;55:329-37.
44. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 years of rheumatoid arthritis: a prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
45. Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003;62:611-6.
46. Wick MC, Anderwald C, Weiss RJ, Imhof H, Kainberger F, Smolen JS. Radiological progression of joint damage in a longitudinal cohort of early DMARD-treated rheumatoid arthritis patients followed for 10 years. Scand J Rheumatol 2004;33:162-6.
47. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
48. Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005;52:1020-30.